Home/News/HHS Proposes COVID Vaccine Injury Table for Compensation Program
MedPage Today2 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

HHS Proposes COVID Vaccine Injury Table for Compensation Program

HHS Proposes COVID Vaccine Injury Table for Compensation Program

The U.S. Department of Health and Human Services (HHS) is initiating steps to create an injury table for COVID-19 countermeasures, including vaccines, under the Countermeasures Injury Compensation Program (CICP). The Health Resources and Services Administration (HRSA), an agency within HHS, posted a notice of its intent to establish this table. This move aims to streamline the process for individuals seeking compensation for injuries attributed to covered countermeasures.

The CICP, established by the Public Readiness and Emergency Preparedness (PREP) Act, provides compensation to individuals who have sustained serious physical injuries as a direct result of the administration or use of covered countermeasures during a public health emergency. Unlike vaccine injury courts, the CICP is an administrative program that does not require claimants to prove negligence. However, it has historically faced criticism for its lengthy processing times and low compensation rates.

Establishing a formal injury table for COVID-19 vaccines and other countermeasures would define specific injuries presumed to be caused by these products. This would shift the burden of proof for certain conditions, making it easier for eligible individuals to demonstrate a link between the countermeasure and their injury. The creation of such a table is a significant procedural step that could impact future compensation claims related to COVID-19 vaccines and other pandemic-related medical interventions.

While the notice signifies the initiation of the process, the specific details of the injury table, including which conditions will be included and the criteria for eligibility, are yet to be determined. The HRSA's action follows ongoing discussions and advocacy from various groups urging for greater transparency and accessibility within the CICP for those affected by COVID-19 countermeasures. The program has been a subject of debate regarding its effectiveness and fairness in compensating individuals for vaccine-related injuries.

Original source — read the full reporting at the publisher:

Read on MedPage Today

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next